US 11759506
AADC polynucleotides for the treatment of Parkinson's disease
granted A61KA61K35/761A61K38/51
Quick answer
US patent 11759506 (AADC polynucleotides for the treatment of Parkinson's disease) held by VOYAGER THERAPEUTICS, INC. expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VOYAGER THERAPEUTICS, INC.
- Grant date
- Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K35/761, A61K38/51, A61K48/005, A61K48/0066